en

PRODUCT DETAIL

POTELIGEO 4 mg/ml koncentrát na infúzny roztok

Code 0507D
MA number EU/1/18/1335/001
Product Form: con inf 1x5 ml/20 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FX Other monoclonal antibodies and antibody drug conjugates
L01FX09 Mogamulizumab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 22.11.2018
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 25.09.2023
eu-flag.png sk-flag.png